ASCLETIS-B (01672) issued a total of 295,600 shares due to the exercise of stock purchase rights.
Gale Pharmaceuticals - B (01672) announced that, due to eligible participants according to the company on June 6, 2019 adopted...
ASCLETIS-B (01672) announced that, as eligible participants exercised their stock options under the company's stock option scheme adopted on June 6, 2019, the company issued a total of 295,600 ordinary shares on September 18, 2025.
Related Articles

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


